DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine https://ift.tt/eA8V8J

The panel also recommended that the proposed clinical trial sites be distributed across India, the source said.

from The Hindu - National https://ift.tt/3jTN3Gc